Syapse

San Francisco, CA, United States Healthcare Acquired

Syapse is a precision-medicine and real-world evidence company focused on oncology. It operates a learning health network of community-based health systems, aggregating clinical, molecular, and treatment data from cancer patients to power real-world evidence offerings used by life-sciences companies, providers, and researchers to improve cancer care and accelerate research. Founded in 2008 and headquartered in San Francisco, Syapse was acquired by N-Power Medicine in a stock-for-stock transaction that closed December 30, 2024 (announced January 13, 2025).

Acquired

Syapse has been acquired

Acquired by N-Power Medicine December 30, 2024

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2008

Employees

51–200

Total Funding

$171M

6 rounds

Funding

Total raised $171M across 6 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

Growth

Date

July 27, 2022

Amount

$35M

Valuation

Lead Investors

Innovatus Capital Partners
DateRoundAmount RaisedValuationLead Investors
July 27, 2022 Growth $35M Innovatus Capital Partners
February 2, 2021 Series E $68M Ally Bridge Group
November 14, 2017 Series D $30M Medidata, Ascension Ventures

Leadership

  • Michael Mentesana

    Chief Executive Officer

  • Tony Loeser

    Co-Founder and CTO

  • Thomas D. Brown

    Chief Medical Officer

  • Vinod Subramanian

    Chief Data and Product Development Officer

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Flatiron Health

    Oncology-focused electronic health record and real-world evidence company; acquired by Roche in 2018.

  • Tempus AI

    Precision-medicine company applying AI to clinical and molecular data, including oncology RWD.

  • ConcertAI

    Oncology real-world data and AI solutions for life-sciences research and clinical trials.

  • COTA

    Oncology real-world data analytics company supporting providers, payers, and life sciences.

  • Caris Life Sciences

    Molecular profiling and precision-medicine company with oncology data services.

  • Komodo Health

    Healthcare data platform providing real-world evidence across therapeutic areas including oncology.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.